Editors:
- Brings together the current knowledge of molecular and translational aspects of AIs resistance in breast cancer
- Provides mechanisms of physiological resistance and potential biomarkers that recognize or predict mechanisms of resistance
- Explores acquired, adjuvant, pre-operative, and metastatic resistance
- Includes supplementary material: sn.pub/extras
Part of the book series: Resistance to Targeted Anti-Cancer Therapeutics (RTACT, volume 8)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (12 chapters)
-
Front Matter
-
Back Matter
About this book
Editors and Affiliations
-
Academic Laboratory of Medical Genetics, School of Clinical Medicine, Cancer Research UK Cambridge Institute, Statistics and Computational Biology Laboratory & University of Cambridge, Cambridge, United Kingdom
Alexey Larionov
About the editor
Bibliographic Information
Book Title: Resistance to Aromatase Inhibitors in Breast Cancer
Editors: Alexey Larionov
Series Title: Resistance to Targeted Anti-Cancer Therapeutics
DOI: https://doi.org/10.1007/978-3-319-17972-8
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer International Publishing Switzerland 2015
Hardcover ISBN: 978-3-319-17971-1Published: 05 May 2015
Softcover ISBN: 978-3-319-38284-5Published: 17 October 2016
eBook ISBN: 978-3-319-17972-8Published: 25 April 2015
Series ISSN: 2196-5501
Series E-ISSN: 2196-551X
Edition Number: 1
Number of Pages: XVI, 288
Number of Illustrations: 29 b/w illustrations, 27 illustrations in colour
Topics: Cancer Research, Drug Resistance, Molecular Medicine